Clinigen France Team

Julie Donjon Pharmaceutical Affairs Director/Responsible Pharmacist (QP)

Julie Donjon joined Clinigen in January 2021 and is currently the Pharmacien Responsible and national PV Responsible Person for Clinigen Healthcare France. She also acts as EU QPPV for Clinigen Healthcare Ltd. Julie started her career at Sanofi Pasteur MSD in 2002 and oversaw the registration of centrally approved vaccines until 2009. Following this experience, she worked in a small French company (Flamel Technologies) in the development of modified released formulations, including PV of clinical trials. She then worked for 5 years at Avadel Pharmaceuticals to develop and register a new narcolepsy treatment with the FDA; she was Head of Pharmaceutical affairs and was working with a Phase III clinical trial. Julie joined Juvisé Pharmaceuticals in 2019 as Head of the Pharmaceuticals Affairs department and participated in the acquisition of two products from Astra Zeneca. Julie is also a member of the AFAR  and AFIPRAL Working groups.

Annabelle Perret Pharmaceutical Affairs Manager

Annabelle  a qualified Pharmacist joined Clinigen in September 2021 through an apprenticeship in Regulatory and Pharmaceutical Affairs. She then transitioned into a permanent position at Clinigen and is currently a Pharmaceutical Affairs Manager. Since September 2023, she has also been acting as the Deputy National PV Responsible person for Clinigen Healthcare France and EUQPPV Deputy for Clinigen Healthcare Ltd.

Nathalie Caizergues Medical Affairs Director

Nathalie has extensive experience in developing and leading national strategic plans and priorities for positioning and development, collaborating with other functions in Clinical Development and Medical Affairs (European and US teams): feasibility studies for clinical trials recruitment/monitoring (phase II & III), centres selection, SIV management, scientific discussions with investigators and collaboration with CROs. She has also managed and participated in local and international congresses & scientific workshops across Europe. She is the strategy lead for Early Access Programs in Europe and relationships with healthcare authorities (ANSM, AIFA) and is a specialist in French regulation. She also has experience with KOL management in relation to the Médical Science Liaison team, medical events organisation: Ad board, Congress, symposium, medical strategy and alliance management.

Christophe Pitre National Account Manager (France)

Christophe worked as a hospital pharmacist in a large public hospital for 20 years. During this period he was Head of the Pharmacy department and Chairman of the Medical Commission. He was involved in the creation of the regional buying group. In 2016 Christophe moved to the third largest private hospital group in France to manage  pharmaceutical affairs and to purchase drugs and medical devices. Christophe joined Clinigen in 2019 to develop sales of commercial products and unlicensed products. He has an intimate knowledge of French private and public hospitals and their buying processes (public procurement law, private contracts). He also has an excellent network of both pharmacists and physicians.

Frédéric Lacote Commercial Director Europe

Frederic has a Pharm D with a Master in Strategic Marketing. 24 years in leading pharmaceutical firms (Astra Zeneca, BMS, Boehringer-Ingelheim, Clinigen). 10 years of promotional marketing, 2 years in business development, 5 years in strategic marketing, 2 years in sales management and 6 years in medical as MSL Director. International experience with Pan-European responsibilities. He developed double digit growth and revenues through the building of new brands, delivering strong results and winning teams. Strong expertise in oncology/haematology (11 years).